Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc.verified

SEEL

Price:

$0.37

Market Cap:

$214.97K

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients ...[Read more]

Industry

Biotechnology

IPO Date

1999-04-19

Stock Exchange

NASDAQ

Ticker

SEEL

The PE Ratio as of November 2025 (TTM) for Seelos Therapeutics, Inc. (SEEL) is 0.00

According to Seelos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.00. This represents a change of -99.99% compared to the average of 8.39 of the last 4 quarters.

Seelos Therapeutics, Inc. (SEEL) Historical PE Ratio (quarterly & annually)

How has SEEL PE Ratio performed in the past?

The mean historical PE Ratio of Seelos Therapeutics, Inc. over the last ten years is 12.11K. The current 0.00 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), SEEL's PE Ratio was at its highest in in the March 2017 quarter at 1.00K. The PE Ratio was at its lowest in in the December 2016 quarter at -32322.95.

Quarterly (TTM)
Annual

Average

12.11K

Median

-375.93

Minimum

-10538.68

Maximum

142.32K

Seelos Therapeutics, Inc. (SEEL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Seelos Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 581.32%

Maximum Annual PE Ratio = 142.32K

Minimum Annual Increase = -6505.80%

Minimum Annual PE Ratio = -10538.68

Quarterly (TTM)
Annual
YearPE RatioChange
2023-22.85-81.18%
2022-121.39-56.77%
2021-280.80-40.39%
2020-471.05581.32%
2019-69.14-86.60%
2018-515.79-100.36%
2017142.32K-6505.80%
2016-2221.67-78.92%
2015-10538.6850.94%
2014-6982.19-66.23%

Seelos Therapeutics, Inc. (SEEL) Average PE Ratio

How has SEEL PE Ratio performed in the past?

The current PE Ratio of Seelos Therapeutics, Inc. (SEEL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-141.68

5-year avg

-193.05

10-year avg

12.11K

Seelos Therapeutics, Inc. (SEEL) PE Ratio vs. Peers

How is SEEL’s PE Ratio compared to its peers?

Seelos Therapeutics, Inc.’s PE Ratio is greater than Virios Therapeutics, Inc. (-0.01), greater than TC Biopharm (Holdings) Plc (-0.04), greater than Bellerophon Therapeutics, Inc. (-0.01), greater than TFF Pharmaceuticals, Inc. (-0.04), greater than LakeShore Biopharma Co., Ltd (-6.35), greater than Akerna Corp. (-0.02), greater than Histogen Inc. (-0.01), greater than ProSomnus, Inc. (-0.32), greater than Immatics N.V. (-10.68),

Build a custom stock screener for Seelos Therapeutics, Inc. (SEEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seelos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seelos Therapeutics, Inc. (SEEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seelos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Seelos Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Seelos Therapeutics, Inc. (SEEL)?

What is the highest PE Ratio for Seelos Therapeutics, Inc. (SEEL)?

What is the 3-year average PE Ratio for Seelos Therapeutics, Inc. (SEEL)?

What is the 5-year average PE Ratio for Seelos Therapeutics, Inc. (SEEL)?

How does the current PE Ratio for Seelos Therapeutics, Inc. (SEEL) compare to its historical average?